Move to Tonsley puts cardiovascular device company c.tech on pathway to further success

An already strong trajectory of success for South Australian medical device company cardiovasc.tech (c.tech) is being further accelerated thanks to a move to Tonsley Innovation District.

In the short time c.tech has been based at Tonsley, the company has expanded its team and network, received unprompted funding and is already collaborating with other precinct members such as ASX listed X-ray technology company Micro-X.

c.tech’s move to the Flinders New Venture Institute at Tonsley comes as the company prepares to launch its next device, which provides crucial monitoring of pacemaker signals during surgery.

“The benefits of being part of the Tonsley ecosystem became apparent almost immediately on moving in,” c.tech founder and Managing Director Darius Chapman said.

“Although we already had the technology, skills and capacity to deliver our devices, we needed to consider how our company was being perceived by those outside our organisation.

“Now we’ve complemented our expertise and technology with a location and a physical presence that underlines the complex challenges we are working to solve in cardiac care. It adds a layer of credibility to our profile and the move has proven to be a real game-changer.

“Within two weeks of being here we had four new student interns who are not only assisting with output but are also extending our networks back into the universities.

“Tonsley is an environment where companies such as ours can really thrive and we’ve certainly experienced that firsthand.”

Renewal SA Executive Director Property and Major Projects Todd Perry said the addition of c.tech to Tonsley’s burgeoning health, medical devices and assistive technologies focus sector was positive proof of the potential benefits on offer.

“Great innovation is often best driven when it’s first and foremost about solving problems,” Mr Perry said.

“c.tech brings important knowledge around commercialisation and incredible innovation to the Tonsley ecosystem.

“It is providing devices to hospitals and patients around the world with strong aspirations for further growth and success. I have no doubt that collaboration with people and companies within the broader Tonsley network will be a real asset and enabler as they look to realise these ambitions.”

About c.tech

The c.tech team brings together a group of professionals with a shared commitment to innovation and excellence in the field of cardiac care. The c.tech journey began with the development of the OnePoint Junction Box – a device which delivers on a crucial unmet need in cardiac care and aims to take the guesswork out of pacemaker surgery.

More than 500 units have now been supplied in 26 countries around the world, with sales heading towards $1 million. TorqView is the company’s next device set for launch in 2024, designed to enable surgeons to accurately deploy pacemakers while seeing precision measurements and positioning in real time.